The estimated Net Worth of S George Simon is at least $204 Tysiąc dollars as of 16 January 2007. S Simon owns over 5,000 units of Myriad Genetics stock worth over $191,266 and over the last 22 years S sold MYGN stock worth over $13,060.
S has made over 6 trades of the Myriad Genetics stock since 2004, according to the Form 4 filled with the SEC. Most recently S exercised 5,000 units of MYGN stock worth $62,700 on 16 January 2007.
The largest trade S's ever made was exercising 10,000 units of Myriad Genetics stock on 5 May 2006 worth over $107,400. On average, S trades about 1,975 units every 57 days since 2003. As of 16 January 2007 S still owns at least 7,278 units of Myriad Genetics stock.
You can see the complete history of S Simon stock trades at the bottom of the page.
S's mailing address filed with the SEC is , , , , .
Over the last 22 years, insiders at Myriad Genetics have traded over $51,783,466 worth of Myriad Genetics stock and bought 61,160 units worth $1,252,955 . The most active insiders traders include Jerry S Lanchbury, Peter D Meldrum oraz Arthur H Jr Hayes. On average, Myriad Genetics executives and independent directors trade stock every 18 days with the average trade being worth of $563,312. The most recent stock trade was executed by Heinrich Dreismann on 9 September 2024, trading 10,000 units of MYGN stock currently worth $270,500.
myriad genetics inc., is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. myriad is focused on three strategic imperatives: maintaining leadership in an expanding hereditary cancer market, diversifying its product portfolio through the introduction of new products and increasing the revenue contribution from international markets. for more information on how myriad is making a difference, please visit the company's website: www.myriad.com.
Myriad Genetics executives and other stock owners filed with the SEC include: